$SIGA
SIGA Technologies Inc Stock $siga

$siga Overview Financials Valuation SEC Filings Company Website

2020 Q2 Form 10-Q Financial Statement

#000143774920016895 Filed on August 06, 2020

Income Statement

Concept	2020 Q2	2019 Q2	2019 Q1
Revenue	$40.35M	$3.908M	$10.46M
YoY Change	932.47%	46.86%	498.34%
Cost Of Revenue	$4.797M	$0.00	$915.0K
YoY Change
Gross Profit	$35.55M	$3.908M	$9.544M
YoY Change	809.72%	46.86%	446.0%
Gross Profit Margin	88.11%	100.0%	91.25%
Selling, General & Admin	$3.871M	$3.392M	$3.167M
YoY Change	14.11%	17.79%	3.58%
% of Gross Profit	10.89%	86.8%	33.18%
Research & Development	$2.710M	$2.038M	$3.997M
YoY Change	32.94%	-38.46%	32.89%
% of Gross Profit	7.62%	52.16%	41.88%
Depreciation & Amortization	$140.0K	$127.6K	$137.7K
YoY Change	9.75%	2982.05%	362.32%
% of Gross Profit	0.39%	3.26%	1.44%
Operating Expenses	$6.581M	$5.613M	$8.267M
YoY Change	17.24%	-11.9%	31.58%
Operating Profit	$28.80M	-$1.705M	$2.192M
YoY Change	-1788.73%	-54.04%	-148.33%
Interest Expense	$0.00	$3.971M	$3.928M
YoY Change	-100.0%	3.33%	4.79%
% of Operating Profit	0.0%		179.22%
Other Income/Expense, Net	$31.93K	$737.6K	$736.1K
YoY Change	-95.67%	411.67%	32836.42%
Pretax Income	$27.21M	-$4.282M	$2.136M
YoY Change	-735.41%	-39.25%	-118.44%
Income Tax	$6.300M	-$1.100M	$506.2K
% Of Pretax Income	23.15%		23.7%
Net Earnings	$20.89M	-$3.162M	$1.630M
YoY Change	-760.56%	-55.15%	-114.07%
Net Earnings / Revenue	51.77%	-80.92%	15.58%
Basic Earnings Per Share	$0.26	-$0.04	$0.02
Diluted Earnings Per Share	$0.26	-$0.05	-$0.02
COMMON SHARES
Basic Shares Outstanding	80.34M	80.99M	80.91M
Diluted Shares Outstanding	80.52M	82.11M	82.14M

Balance Sheet

Concept	2020 Q2	2019 Q2	2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$53.10M	$100.3M	$102.1M
YoY Change	-47.06%	846.23%	634.53%
Cash & Equivalents	$53.07M	$100.3M	$102.1M
Short-Term Investments
Other Short-Term Assets	$1.400M	$14.70M	$15.40M
YoY Change	-90.48%	-86.24%	20.31%
Inventory	$14.01M	$2.390M	$2.017M
Prepaid Expenses
Receivables	$36.61M	$4.128M	$4.100M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$105.1M	$121.5M	$123.5M
YoY Change	-13.55%	-0.69%	299.38%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.366M	$2.860M	$2.987M
YoY Change	-17.26%	2057.18%	2644.54%
Goodwill	$898.3K	$898.3K	$898.3K
YoY Change	0.0%	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$901.9K	$930.0K	$993.0K
YoY Change	-3.02%	17.73%	41.41%
Total Long-Term Assets	$15.35M	$81.56M	$82.90M
YoY Change	-81.18%	1267.4%	-18.89%
TOTAL ASSETS
Total Short-Term Assets	$105.1M	$121.5M	$123.5M
Total Long-Term Assets	$15.35M	$81.56M	$82.90M
Total Assets	$120.4M	$203.1M	$206.4M
YoY Change	-40.71%	58.24%	55.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$630.2K	$1.071M	$2.150M
YoY Change	-41.16%	-24.19%	397.36%
Accrued Expenses	$14.93M	$10.05M	$9.958M
YoY Change	48.54%	205.69%	177.67%
Deferred Revenue	$10.63M
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00
YoY Change
Total Short-Term Liabilities	$15.56M	$11.12M	$12.11M
YoY Change	39.9%	-97.08%	201.3%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$77.80M	$76.70M
YoY Change	-100.0%	6.14%	6.23%
Other Long-Term Liabilities	$10.70M	$10.70M	$11.60M
YoY Change	0.0%	-29.14%	-97.04%
Total Long-Term Liabilities	$10.70M	$88.50M	$88.30M
YoY Change	-87.91%	0.11%	-80.96%
TOTAL LIABILITIES
Total Short-Term Liabilities	$15.56M	$11.12M	$12.11M
Total Long-Term Liabilities	$10.70M	$88.50M	$88.30M
Total Liabilities	$26.28M	$99.64M	$100.4M
YoY Change	-73.62%	-78.79%	-78.54%
SHAREHOLDERS EQUITY
Retained Earnings	-$127.3M	-$117.3M	-$114.2M
YoY Change	8.47%	-78.91%	-57180.74%
Common Stock	$221.4M	$220.8M	$220.2M
YoY Change	0.28%	2.73%	2.64%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$94.13M	$103.5M	$106.1M
YoY Change
Total Liabilities & Shareholders Equity	$120.4M	$203.1M	$206.4M
YoY Change	-40.71%	58.24%	55.06%

Cashflow Statement

Concept	2020 Q2	2019 Q2	2019 Q1
OPERATING ACTIVITIES
Net Income	$20.89M	-$3.162M	$1.630M
YoY Change	-760.56%	-55.15%	-114.07%
Depreciation, Depletion And Amortization	$140.0K	$127.6K	$137.7K
YoY Change	9.75%	2982.05%	362.32%
Cash From Operating Activities	-$9.090M	-$4.350M	$9.379K
YoY Change	108.97%	-16.18%	-100.11%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$0.00	-$10.00K
YoY Change		-100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$0.00	$0.00	-$8.951K
YoY Change		-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-15.22M	0.000	-56.59K
YoY Change		-100.0%
NET CHANGE
Cash From Operating Activities	-9.090M	-4.350M	9.379K
Cash From Investing Activities	0.000	0.000	-8.951K
Cash From Financing Activities	-15.22M	0.000	-56.59K
Net Change In Cash	-24.31M	-4.350M	-56.16K
YoY Change	458.85%	-16.83%	-99.34%
FREE CASH FLOW
Cash From Operating Activities	-$9.090M	-$4.350M	$9.379K
Capital Expenditures	$0.00	$0.00	-$10.00K
Free Cash Flow	-$9.090M	-$4.350M	$19.38K
YoY Change	108.97%	-15.7%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	81269868
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	81269868
	siga	Increase Decrease In Deferred Tax Assets IncreaseDecreaseInDeferredTaxAssets	-700000	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	180041785	USD
CY2019Q2	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2019	siga	Lessee Operating Lease First Renewal Term LesseeOperatingLeaseFirstRenewalTerm	P2Y
CY2019	siga	Lessee Operating Lease Second Renewal Term LesseeOperatingLeaseSecondRenewalTerm	P3Y
CY2020Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	53065833	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	65249072	USD
CY2020Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	0	USD
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	95737862	USD
CY2020Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	36611661	USD
CY2020Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	78618743
CY2020Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	78618743
CY2020Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	78120811
CY2020Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4167996	USD
CY2020Q2	us-gaap	Inventory Net InventoryNet	14006986	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	9652855	USD
CY2020Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1382499	USD
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5234000	USD
CY2020Q2	us-gaap	Assets Current AssetsCurrent	105066979	USD
CY2020Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2366135	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	8127	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2618303	USD
CY2020Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	11183600	USD
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	14151002	USD
CY2020Q2	us-gaap	Goodwill Goodwill	898334	USD
CY2019Q4	us-gaap	Goodwill Goodwill	898334	USD
CY2020Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	901906	USD
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	856766	USD
CY2020Q2	us-gaap	Assets Assets	120416954	USD
CY2019Q4	us-gaap	Assets Assets	198566190	USD
CY2020Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	630165	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3054032	USD
CY2020Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	14931370	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8636911	USD
CY2020Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	0	USD
CY2019Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	80044866	USD
CY2020Q2	us-gaap	Liabilities Current LiabilitiesCurrent	15561535	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	91735809	USD
CY2020Q2	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	7752534	USD
CY2019Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	6116882	USD
CY2020Q2	us-gaap	Other Liabilities OtherLiabilities	2969867	USD
CY2019Q4	us-gaap	Other Liabilities OtherLiabilities	2929743	USD
CY2020Q2	us-gaap	Liabilities Liabilities	26283936	USD
CY2019Q4	us-gaap	Liabilities Liabilities	100782434	USD
CY2020Q2	us-gaap	Common Stock Value CommonStockValue	7862	USD
CY2020Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	221380828	USD
CY2019Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	220808037	USD
CY2020Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-127255672	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-123032408	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	94133018	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	97783756	USD
CY2020Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	120416954	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	198566190	USD
CY2020Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	40348777	USD
CY2019Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3907611	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	42968542	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	14366695	USD
CY2020Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4796768	USD
CY2019Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	0	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4905863	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	915367	USD
CY2020Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3870927	USD
CY2019Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3392228	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7046952	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6558794	USD
CY2020Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2709743	USD
CY2019Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2038323	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5859847	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6035604	USD
CY2020Q2	siga	Patent Preparation Fees PatentPreparationFees	174203	USD
CY2019Q2	siga	Patent Preparation Fees PatentPreparationFees	182310	USD
	siga	Patent Preparation Fees PatentPreparationFees	356800	USD
	siga	Patent Preparation Fees PatentPreparationFees	370226	USD
CY2020Q2	us-gaap	Costs And Expenses CostsAndExpenses	11551641	USD
CY2019Q2	us-gaap	Costs And Expenses CostsAndExpenses	5612861	USD
CY2020Q2	siga	Gain Loss On Change In Fair Value Of Warrant Liability GainLossOnChangeInFairValueOfWarrantLiability	1619587	USD
	us-gaap	Costs And Expenses CostsAndExpenses	18169462	USD
	us-gaap	Costs And Expenses CostsAndExpenses	13879991	USD
CY2020Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	28797136	USD
CY2019Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1705250	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	24799080	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	486704	USD
CY2019Q2	siga	Gain Loss On Change In Fair Value Of Warrant Liability GainLossOnChangeInFairValueOfWarrantLiability	-656523	USD
	siga	Gain Loss On Change In Fair Value Of Warrant Liability GainLossOnChangeInFairValueOfWarrantLiability	1635652	USD
	siga	Gain Loss On Change In Fair Value Of Warrant Liability GainLossOnChangeInFairValueOfWarrantLiability	-3792788	USD
CY2020Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2019Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-4981461	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2020Q2	us-gaap	Interest Expense InterestExpense	-0	USD
CY2019Q2	us-gaap	Interest Expense InterestExpense	3971031	USD
	us-gaap	Interest Expense InterestExpense	3016817	USD
	us-gaap	Interest Expense InterestExpense	7899449	USD
CY2020Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	31931	USD
CY2019Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	737577	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	444295	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1473706	USD
CY2020Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	27209480	USD
CY2019Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-4282181	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	15609445	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-2146251	USD
CY2020Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6319322	USD
CY2019Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1119689	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3616816	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-613536	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	20890158	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-3162492	USD
	us-gaap	Net Income Loss NetIncomeLoss	11992629	USD
	us-gaap	Net Income Loss NetIncomeLoss	-1532715	USD
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.26
CY2019Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.15
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.26
CY2019Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.15
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2020Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	80340695
CY2019Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	80986524
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	80790400
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	80950124
CY2020Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	80516863
CY2019Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	82114661
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	80959812
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	82129601
	us-gaap	Net Income Loss NetIncomeLoss	11992629	USD
	us-gaap	Net Income Loss NetIncomeLoss	-1532715	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	267669	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	265289	USD
	siga	Gain Loss On Change In Fair Value Of Warrant Liability GainLossOnChangeInFairValueOfWarrantLiability	1635652	USD
	siga	Gain Loss On Change In Fair Value Of Warrant Liability GainLossOnChangeInFairValueOfWarrantLiability	-3792788	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	582549	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	956284	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2967402	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-655139	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-4981461	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-0	USD
	us-gaap	Paid In Kind Interest PaidInKindInterest	887132	USD
	us-gaap	Paid In Kind Interest PaidInKindInterest	2230153	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	32443665	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2169083	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1751459	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-517724	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-1203690	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-942599	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-4421690	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2304892	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	8332405	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1204135	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5766225	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4338433	USD
	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	15501	USD
	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	8948	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-15501	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8948	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	9746	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	56590	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	16216170	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	-0	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	85913459	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	-0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-102139375	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-56590	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-107921101	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-4403971	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	160986934	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	180396910	USD
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	53065833	USD
CY2019Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	175992939	USD
	siga	Conversion Of Warrants To Common Stock ConversionOfWarrantsToCommonStock	0	USD
	siga	Conversion Of Warrants To Common Stock ConversionOfWarrantsToCommonStock	1172801	USD
	us-gaap	Stock Issued1 StockIssued1	0	USD
	us-gaap	Stock Issued1 StockIssued1	118500	USD
CY2020Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	142800000	USD
CY2020Q2	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	2500000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	100652809	USD
CY2019Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	11248400	USD
CY2018Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	11452078	USD
CY2019Q2	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	64480624	USD
CY2018Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	68292023	USD
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	100000	USD
CY2020Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	53065833	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	65249072	USD
CY2020Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	0	USD
CY2019Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	95737862	USD
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	53065833	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	160986934	USD
CY2019Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	100263915	USD
CY2019Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	175992939	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	180396910	USD
CY2020Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	2602672	USD
CY2019Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	0	USD
CY2020Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	11315916	USD
CY2019Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	8693457	USD
CY2020Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	88398	USD
CY2019Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	959398	USD
CY2020Q2	us-gaap	Inventory Net InventoryNet	14006986	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	9652855	USD
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	419709	USD
CY2019Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	2966139	USD
CY2020Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	10630746	USD
CY2019Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2298341	USD
CY2020Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2944932	USD
CY2020Q2	us-gaap	Interest Payable Current InterestPayableCurrent	0	USD
CY2019Q4	us-gaap	Interest Payable Current InterestPayableCurrent	977724	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2944932	USD
CY2020Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6360117	USD
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6344616	USD
CY2020Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3993982	USD
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3726313	USD
CY2020Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2366135	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2618303	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	267669	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	265289	USD
CY2020Q2	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	1747880	USD
CY2020Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	434132	USD
CY2020Q2	siga	Accrued Research And Development Vendor Costs Current AccruedResearchAndDevelopmentVendorCostsCurrent	298626	USD
CY2020Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	USD
CY2019Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	656523	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	3792788	USD
CY2019Q4	siga	Accrued Research And Development Vendor Costs Current AccruedResearchAndDevelopmentVendorCostsCurrent	707685	USD
CY2020Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	447451	USD
CY2019Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	288707	USD
CY2020Q2	us-gaap	Accrued Vacation Current AccruedVacationCurrent	438599	USD
CY2019Q4	us-gaap	Accrued Vacation Current AccruedVacationCurrent	256402	USD
CY2020Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	933936	USD
CY2019Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	722204	USD
CY2020Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	14931370	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8636911	USD
CY2019Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	6116882	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-1635652	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	0	USD
CY2020Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	7752534	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	20890158	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-3162492	USD
	us-gaap	Net Income Loss NetIncomeLoss	11992629	USD
	us-gaap	Net Income Loss NetIncomeLoss	-1532715	USD
CY2020Q2	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	20890158	USD
	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	11992629	USD
	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-5325503	USD
CY2020Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	80340695
CY2019Q2	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-3819015	USD
CY2019Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	80986524
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	80790400
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	80950124
CY2020Q2	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	176168
CY2019Q2	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	1128137
	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	169412
	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	1179477
CY2020Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	80516863
CY2019Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	82114661
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	80959812
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	82129601
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.26
CY2019Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.15
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.26
CY2019Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.15
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2020Q2	us-gaap	Purchase Commitment Remaining Minimum Amount Committed PurchaseCommitmentRemainingMinimumAmountCommitted	21300000	USD
	us-gaap	Tax Adjustments Settlements And Unusual Provisions TaxAdjustmentsSettlementsAndUnusualProvisions	19000	USD
CY2020Q2	us-gaap	Income Tax Receivable IncomeTaxReceivable	700000	USD
CY2020Q2	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	27200000	USD
CY2019Q2	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-4300000	USD
CY2020Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6300000	USD
CY2019Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1100000	USD
	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	15600000	USD
	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-2100000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3600000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-600000	USD
CY2020Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.232	pure
CY2019Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.262	pure
CY2020Q2	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.232	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.286	pure
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2020Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	15222795	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	88142122	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	20890158	USD
CY2020Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	-0	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	USD
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	323533	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	94133018	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	97783756	USD
	us-gaap	Net Income Loss NetIncomeLoss	11992629	USD
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	16216170	USD
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	9746	USD
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	582549	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	94133018	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	106069569	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-3162492	USD
CY2019Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	USD
CY2019Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	547390	USD
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	103454467	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	102914687	USD
	us-gaap	Net Income Loss NetIncomeLoss	-1532715	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	USD
	siga	Stock Issued During Period Value Stock Settled Appreciation Rights Exercised StockIssuedDuringPeriodValueStockSettledAppreciationRightsExercised	0	USD
	siga	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	1172801	USD
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	56590	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	956284	USD
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	103454467	USD
CY2020Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	50000000	USD
CY2020Q2	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	2500000
	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	2800000
CY2020Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	15200000	USD
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	16200000	USD
CY2020Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	100000	USD
CY2019Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	100000	USD
	us-gaap	Operating Lease Cost OperatingLeaseCost	300000	USD
	us-gaap	Operating Lease Cost OperatingLeaseCost	300000	USD
CY2020Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	100000	USD
CY2019Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	100000	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	300000	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	300000	USD
CY2020Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y11M12D
CY2020Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0453	pure
CY2020Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	247288	USD
CY2020Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	600362	USD
CY2020Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	368467	USD
CY2020Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	402078	USD
CY2020Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	418153	USD
CY2020Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	2587180	USD
CY2020Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	404258	USD
CY2020Q2	siga	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	982880	USD
CY2020Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	3005333	USD

Files In Submission

Name	View Source	Status
0001437749-20-016895-index-headers.html	Edgar Link	pending
0001437749-20-016895-index.html	Edgar Link	pending
0001437749-20-016895.txt	Edgar Link	pending
0001437749-20-016895-xbrl.zip	Edgar Link	pending
ex_189099.htm	Edgar Link	pending
ex_189100.htm	Edgar Link	pending
ex_189101.htm	Edgar Link	pending
ex_189102.htm	Edgar Link	pending
ex_194496.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
siga-20200630.xsd	Edgar Link	pending
siga-20200630_cal.xml	Edgar Link	unprocessable
siga-20200630_def.xml	Edgar Link	unprocessable
siga-20200630_lab.xml	Edgar Link	unprocessable
siga-20200630_pre.xml	Edgar Link	unprocessable
siga20200630_10q.htm	Edgar Link	pending
siga20200630_10q_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SIGA
SIGA Technologies Inc Stock $siga

2020 Q2 Form 10-Q Financial Statement

#000143774920016895 Filed on August 06, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SIGA SIGA Technologies Inc Stock $siga

2020 Q2 Form 10-Q Financial Statement

#000143774920016895 Filed on August 06, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SIGA
SIGA Technologies Inc Stock $siga